Congenital Adrenal Hyperplasia, Ovarian Failure and Ehlers-Danlos Syndrome due to a 6p Deletion

Nenhuma Miniatura disponível
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Autores
MOYSES-OLIVEIRA, Mariana
MANCINI, Tatiane I.
TAKENO, Sylvia S.
RODRIGUES, Andressa D. S.
MELARAGNO, Maria Isabel
Citação
SEXUAL DEVELOPMENT, v.8, n.4, p.139-145, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Cryptic deletions in balanced de novo translocations represent a frequent cause of abnormal phenotypes, including Mendelian diseases. In this study, we describe a patient with multiple congenital abnormalities, such as late-onset congenital adrenal hyperplasia (CAH), primary ovarian failure and Ehlers-Danlos syndrome (EDS), who carries a de novo t(6;14)(p21;q32) translocation. Genomic array analysis identified a cryptic 1.1-Mb heterozygous deletion, adjacent to the breakpoint on chromosome 6, extending from 6p21.33 to 6p21.32 and affecting 85 genes, including CYP21A2,TNXB and MSH5. Multiplex ligation-dependent probe amplification analysis of the 6p21.3 region was performed in the patient and her family and revealed a 30-kb deletion in the patient's normal chromosome 6, inherited from her mother, resulting in homozygous loss of genes CYP21A1P and C4B. CYP21A2 sequencing showed that its promoter region was not affected by the 30-kb deletion, suggesting that the deletion of other regulatory sequences in the normal chromosome 6 caused a loss of function of the CYP21A2 gene. EDS and primary ovarian failure phenotypes could be explained by the loss of genes TNXB and MSH5, a finding that may contribute to the characterization of disease-causing genes. The detection of this de novo microdeletion drastically reduced the estimated recurrence risk for CAH in the family. (C) 2014 S. Karger AG, Basel
Palavras-chave
Balanced translocation, Congenital adrenal hyperplasia, CYP21A2, Premature ovarian failure, SNP array
Referências
  1. Araujo RS, 2007, J CLIN ENDOCR METAB, V92, P4028, DOI 10.1210/jc.2006-2163
  2. Baptista J, 2008, AM J HUM GENET, V82, P927, DOI 10.1016/j.ajhg.2008.02.012
  3. Bedeschi MF, 2010, MOL SYNDROMOL, V1, P239
  4. Elisa A, 2002, J CLIN ENDOCR METAB, V87, P4314, DOI 10.1210/jc.2001-011939
  5. Borg I, 2002, J MED GENET, V39, P391, DOI 10.1136/jmg.39.6.391
  6. Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104
  7. Chen WY, 2009, AM J MED GENET A, V149A, P2803, DOI 10.1002/ajmg.a.33092
  8. Costa-Barbosa FA, 2010, CLIN ENDOCRINOL, V73, P700, DOI 10.1111/j.1365-2265.2010.03871.x
  9. Cox JJ, 2003, J MED GENET, V40, P169, DOI 10.1136/jmg.40.3.169
  10. Cozzolino M, 2011, MOL GENET METAB, V104, P706, DOI 10.1016/j.ymgme.2011.09.031
  11. De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787
  12. Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075
  13. Fonseca ACS, 2013, CLIN GENET, V83, P169, DOI 10.1111/j.1399-0004.2012.01854.x
  14. Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141
  15. Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374
  16. Kulikowski LD, 2008, AM J MED GENET A, V146A, P2663, DOI 10.1002/ajmg.a.32510
  17. L'Allemand D, 2000, J CLIN ENDOCR METAB, V85, P4562, DOI 10.1210/jc.85.12.4562
  18. Lee HH, 2000, CLIN CHEM, V46, P606
  19. Lindstrand A, 2010, CLIN GENET, V77, P552, DOI 10.1111/j.1399-0004.2009.01341.x
  20. Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049
  21. Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400
  22. Papadopoulou E, 2010, AM J MED GENET A, V152A, P1515, DOI 10.1002/ajmg.a.33302
  23. Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939
  24. Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011
  25. Sismani C, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-15
  26. Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631
  27. Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1
  28. White PC, 2012, SEMIN REPROD MED, V30, P400, DOI 10.1055/s-0032-1324724
  29. Wijesuriya SD, 1999, J BIOL CHEM, V274, P38097, DOI 10.1074/jbc.274.53.38097
  30. Wirth J, 1999, J MED GENET, V36, P271
  31. Yang Y, 2012, GENE, V502, P154, DOI 10.1016/j.gene.2012.04.036
  32. Zweers MC, 2003, AM J HUM GENET, V73, P214, DOI 10.1086/376564